1 – 15 of 109
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Animal models for preclinical Parkinson´s research: An update and critical appraisal
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Molecular Mechanisms of L-DOPA-Induced Dyskinesia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy
(
- Contribution to journal › Article
- 2016
-
Mark
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
(
- Contribution to journal › Letter
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
2016) p.155-188(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
(
- Contribution to journal › Article
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
(
- Contribution to journal › Article
-
Mark
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
(
- Contribution to journal › Article
- 2015
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
(
- Contribution to journal › Scientific review
-
Mark
Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine
(
- Contribution to journal › Article
-
Mark
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
(
- Contribution to journal › Article